MW
1,419.53 g/mol
Purity
>99%
Tissue Repair
BPC-157
Body Protective Compound
Derived from a protective protein found in human gastric juice
$75
Per vial · Research use only · COA available
Compound Profile
| Appearance | Lyophilized white powder |
| Molecular Weight | 1,419.53 g/mol |
| Amino Acids | 15 |
| Dosage | 10 mg |
| Volume | 5 mL |
| Solubility | Bacteriostatic or sterile water |
| Purity | ≥98% (HPLC-UV-MS verified) |
| Storage | −20°C long-term · 4°C short-term · Protect from light |
Amino Acid Sequence
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
For Research Use Only. This product is not for human consumption, clinical use, or veterinary use. Must be 21+ to purchase. Not evaluated or approved by the FDA for any therapeutic use. Introduction into humans or animals is strictly prohibited by law.
Overview
About BPC-157
BPC-157 is a pentadecapeptide — a 15 amino acid sequence — derived from a protective protein found in human gastric juice. It is one of the most studied peptides in regenerative research, examined extensively for its role in tissue repair, gut health, and systemic healing responses. Its designation as a 'body protective compound' reflects the breadth of its studied biological activity.
Mechanism of Action
How It Works
Research indicates BPC-157 promotes healing by upregulating growth hormone receptor expression in tendon fibroblasts and modulating key growth factors including VEGF and EGF. It also influences nitric oxide production, exhibits cytoprotective properties across multiple tissue types, and has demonstrated activity in the gut-brain axis, suggesting cross-system relevance beyond localized tissue repair.
Scientific Literature
Research Highlights
Accelerated healing of muscle, tendon, ligament, and bone in animal models
Cytoprotective activity in gastrointestinal tissue — studied in ulcerative colitis models
Upregulation of growth hormone receptor expression in tendon fibroblasts
CNS-relevant effects via the gut-brain axis — neuroprotective potential observed
Modulation of nitric oxide synthesis — implications for vascular and tissue repair
Anti-inflammatory cytokine modulation in preclinical studies
Studied in multiple sclerosis and inflammatory bowel disease research contexts
Research Disclaimer: All research highlights are derived from published preclinical, in vitro, and animal studies. Results observed in laboratory models may not translate to human outcomes. Genfinite makes no claims regarding therapeutic efficacy. All products are sold strictly for scientific research purposes only.
Handling
Storage & Reconstitution
Dry Storage
Store lyophilized powder at −20°C, away from light and moisture. Do not open until ready to use. Shelf life is significantly extended by proper dry storage.
Reconstitution
Reconstitute using Bacteriostatic or sterile water. Add solvent slowly to the side of the vial and allow to dissolve gently. Do not shake vigorously.
Post-Reconstitution
Store reconstituted solution refrigerated at 4°C. Use within your laboratory's established timeframe. Do not refreeze after reconstitution.
